Cargando…

Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP)

INTRODUCTION: Psychosis, including hallucinations and delusions, is one of the important non-motor problems in patients with Parkinson's disease (PD) and is possibly associated with cholinergic neuronal degeneration. The EDAP (Efficacy of Donepezil against Psychosis in PD) study will evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawada, Hideyuki, Oeda, Tomoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787472/ https://www.ncbi.nlm.nih.gov/pubmed/24071461 http://dx.doi.org/10.1136/bmjopen-2013-003533

Ejemplares similares

Correction: Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP)
Publicado: (2016)

Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years
por: Sawada, Hideyuki, et al.
Publicado: (2018)

Catecholamines and Neurodegeneration in Parkinson’s Disease—From Diagnostic Marker to Aggregations of α-Synuclein
por: Sawada, Hideyuki, et al.
Publicado: (2013)

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
por: Sawada, Hideyuki, et al.
Publicado: (2010)

Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study
por: Sawada, Hideyuki, et al.
Publicado: (2013)

Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Clinical Factors Associated with Abnormal Postures in Parkinson's Disease
por: Oeda, Tomoko, et al.
Publicado: (2013)

Efficacy and safety of the Chaihuguizhiganjiang-suanzaoren granule on primary insomnia: study protocol for a randomised controlled trial
por: Liu, Qing-Quan, et al.
Publicado: (2016)

Correction: Clinical Factors Associated with Abnormal Postures in Parkinson's Disease
por: Oeda, Tomoko, et al.
Publicado: (2013)

Efficacy and safety of the Chaixiong Qiwei granule for tension-type headache: study protocol for a randomised controlled trial
por: Shen, Wei, et al.
Publicado: (2023)

Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson’s symptoms against other clinical monitoring methods: study protocol
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2021)

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol
por: Greenland, Julia C, et al.
Publicado: (2020)

Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
por: Gan, Jing, et al.
Publicado: (2019)

Pimavanserin in Parkinson’s Disease-induced Psychosis: A Literature Review
por: Patel, Rikinkumar S, et al.
Publicado: (2019)

Study protocol for a single-blind randomised controlled trial to evaluate the clinical effects of an Integrated Qigong exercise intervention on freezing of gait in Parkinson’s disease
por: Li, Zhenlan, et al.
Publicado: (2019)

Delirium and High Fever Are Associated with Subacute Motor Deterioration in Parkinson Disease: A Nested Case-Control Study
por: Umemura, Atsushi, et al.
Publicado: (2014)

Efficacy and safety of human-derived neural stem cell in patients with ischaemic stroke: study protocol for a randomised controlled trial
por: Xie, Chong, et al.
Publicado: (2022)

Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
por: Abler, Victor, et al.
Publicado: (2022)

Efficacy and neural mechanism of acupuncture treatment in older adults with subjective cognitive decline: study protocol for a randomised controlled clinical trial
por: Yan, Chao-Qun, et al.
Publicado: (2019)

The Efficacy of Tai Chi and Stretching Exercises Based on a Smartphone Application for Patients With Parkinson's Disease: A Protocol for a Randomized Controlled Trial
por: Ma, Renyan, et al.
Publicado: (2021)

Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
por: Payne, Thomas, et al.
Publicado: (2020)

Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study
por: Sawada, Hideyuki, et al.
Publicado: (2014)

Diagnostic Accuracy of Apparent Diffusion Coefficient and (123)I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson’s Disease
por: Umemura, Atsushi, et al.
Publicado: (2013)

Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease
por: Sawada, Hideyuki, et al.
Publicado: (2015)

Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon
por: Malik, Bilal Haider, et al.
Publicado: (2019)

Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease
por: Umemura, Atsushi, et al.
Publicado: (2015)

Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson’s disease
por: Tomita, Satoshi, et al.
Publicado: (2018)

Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
por: Carroll, Camille B, et al.
Publicado: (2019)

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial
por: McKee, Justin B, et al.
Publicado: (2015)

Efficacy of probucol on cognitive function in Alzheimer’s disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study)
por: Lam, Virginie, et al.
Publicado: (2022)

Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis
por: Mantri, Sneha, et al.
Publicado: (2021)

Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial
por: Cui, Xiao-Ping, et al.
Publicado: (2016)

Group interventions for amyotrophic lateral sclerosis caregivers in Ireland: a randomised controlled trial protocol
por: Burke, Tom, et al.
Publicado: (2019)

Shunting outcomes in communicating hydrocephalus: protocol for a multicentre, open-label, randomised controlled trial
por: Sun, Tong, et al.
Publicado: (2021)

Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial
por: Ray, Jason Charles, et al.
Publicado: (2022)

Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): study protocol for a randomised placebo-controlled trial
por: Zhang, Xuelei, et al.
Publicado: (2021)

Comorbid Depression and Psychosis in Parkinson’s Disease: A Report of 62,783 Hospitalizations in the United States
por: Imran, Sundus, et al.
Publicado: (2019)

Aneurysmal subarachnoid haemorrhage—cerebral vasospasm and prophylactic ibuprofen: a randomised controlled pilot trial protocol
por: Dayyani, Mojtaba, et al.
Publicado: (2022)

The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis
por: Killin, Lewis O J, et al.
Publicado: (2014)

Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial
por: Zeng, Liling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e4qeb9n0n3jq0ke3d1126l71br